Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Press Statements

      Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19

      Drug Development
      Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,...

      Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment

      Clinical Trials
      Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment...

      Fujifilm to invest 100 billion yen to expand its large scale biologics production facility in Denmark

      Manufacturing
      FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark site of FUJIFILM Diosynth Biotechnologies,...

      Sun Pharma initiates Phase-II clinical trial on AQCH for treatment of COVID-19 patients

      Asia
      Sun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatment of COVID-19....

      AI to deliver next evolution of drug manufacturing and supply chain efficiency

      Drug Development
      In the absence of ‘in person’ meetings, access to deep dive pharma insights are not on hold, and later this month experts will discuss...

      FDA Approves Merck’s RECARBRIO for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

      FDA Approvals
      Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for...

      Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients

      Clinical Trials
      Sun Pharmaceutical Industries Ltd. has announced that it has received approval from the Drugs Controller General of India (DCGI) to initiate a clinical trial...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.